Shares of Dr. Martens plc (LON:DOCS - Get Free Report) shot up 25.8% during trading on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). 8,364,149 shares were traded during trading, an increase of 271% from the average session volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada decreased their price target on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Read Our Latest Stock Analysis on DOCS
Dr. Martens Stock Performance
The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The stock has a market capitalization of £795.54 million, a P/E ratio of 11.62, a PEG ratio of 6.40 and a beta of 0.11. The business has a 50-day moving average price of GBX 54.73 and a 200 day moving average price of GBX 62.64.
Dr. Martens (LON:DOCS - Get Free Report) last released its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, sell-side analysts forecast that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Dr. Martens Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were given a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's dividend payout ratio (DPR) is 42.53%.
Insiders Place Their Bets
In other Dr. Martens news, insider Giles Wilson bought 32,640 shares of Dr. Martens stock in a transaction on Tuesday, March 25th. The stock was acquired at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,934.82). Over the last ninety days, insiders bought 33,206 shares of company stock valued at $1,792,771. Insiders own 4.36% of the company's stock.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
See Also
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
